Novel antioxidant formulations
OwnerPhillip E. Schoenwetterinventor
Life of this patent
Estimating the term…
Abstract
An antioxidant composition comprises one or more amino acids; a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof; and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.
Claims19
An antioxidant composition comprising:
- one or more amino acids;
- a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof;
- and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.
A method for a mammal to mitigate oxidative stress, the method comprising:
- providing an antioxidant composition in a dietary supplement form;
- and
- causing the mammal to intake the antioxidant composition such that the antioxidant composition reduces damage to the mammal's DNA caused by the oxidative stress,
- wherein the antioxidant composition comprises one or more amino acids;
- a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof;
- and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.
A method of treating a mammal with one or more of the following conditions and ailments including osteoporosis, exposure to radiation, gonad hormone deficiency either natural or surgical caused, exposure to water or/and air pollution, exposure to outdoor environments, and exposure to natural or artificial light, the method comprising causing the mammal with the ailments or conditions to ingest or intake a composition comprising one or more amino acids;
- a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof;
- and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.
Dependencies are inferred from the claim text.